Breast Diseases Clinical Trial
Official title:
Oncoplastic Approach to Excisional Breast Biopsies: A Prospective Randomized Controlled Trial
Many studies focusing on breast conserving surgery have affirmed the cosmetic effectiveness and oncologic success of oncoplastic methods and even modified variants of these methods reinforced with videoscopic applications. However, primary lumpectomy subjects in these studies are mainly patients who have already received the diagnosis of malignancy before the surgery. There is not much comprehensive work reported for patients without the diagnosis of malignancy. In this regard, the investigators believe the intent of the innovative oncoplastic intervention to the breast is underestimated in terms of providing diagnosis simultaneously constituting the basic component of surgical treatment. Thus, the purpose of this prospectively planned study is to provide and investigate the outcomes of an evidence-based oncoplastic approach algorithm for excisional breast biopsies.
Excisional breast biopsy is one of the routine surgical interventions in general surgery
clinics, implemented for clinical diagnosis of suspicious breast lesions. It is the
diagnostic method of choice especially when fine needle aspiration biopsy (FNA), core cutting
needle (trucut) biopsy or vacuum-assisted core biopsy as part of a non-invasive approach can
not provide sufficient diagnostic efficiency for the diagnosis of non-palpable breast
lesions. This invasive biopsy approach must be selectively tailored according to the nature
of the lesion, either directly or as a second-stage procedure, necessarily, if a sufficiently
precise diagnosis cannot be reached after practicing less-invasive protocols. By definition,
basic difference from a segmental mastectomy or a lumpectomy is that excisional breast biopsy
is a surgical procedure to remove suspicious breast tissue and a small amount of normal
tissue around it only before the pathologic diagnosis is confirmed.
Prebiopsy localisation modalities like wire-guidance or radioisotope occult lesion
localization (ROLL) are proven to reduce the rates of margin positivity at initial
lumpectomies in breast cancer. Accomplishing the excision as a whole with a 1 cm layer of
normal tissue around by means of an incision confined to possible mastectomy line, whilst
preserving the skin if it is 1cm far away from the suspicious area and a three-dimensional
marking on the specimen are considered to be general principles in conventional excisional
breast biopsies. In the same way, another ground rule would be close collaboration with
plastic and reconstructive surgery department, especially when significant relative breast
volume loss is anticipated and defect should be restored using volume replacement methods or
when the nipple and areola complex (NAC) is under threat. It is imperative that the patient
be informed of the common risks and reasonable alternatives to the proposed treatment. For
patients seeking additional advice on NAC disturbances it is important to keep in mind that
the tattoo art might be an appealing suggestion; many consider tattooing as a practical
complementary solution for sequela after reconstruction of Nipple-areolar complex.
On the other hand, in the vast majority of the cases the mainstay of treatment does not
entail surgical resection of NAC or requisite volume replacement, but still there is debate
as to whether surgeons should place parenchymal sutures to approximate the cut edges of the
cavity walls. The rationale behind this debate is that closure of the tissue defect with
direct suture approximation brings about a considerable heterogeneity when it comes to
cosmetic parameters. Besides, in many cases, when not coupled with overlying skin dissection
after probable dimples observed on the skin while knotting each suture, this modality is
ended up too far off target to merit the highest degree of patient satisfaction. Fortunately,
surgical algorithms for breast tumors have been refined a great deal in recent years with
rapid developments and key technique definitions in the field of oncoplastic surgery and
opinions favoring parenchymal sutures have been strengthened.
Many studies focusing on breast conserving surgery have affirmed the cosmetic effectiveness
and oncologic success of oncoplastic methods and even modified variants of these methods
reinforced with videoscopic applications. However, primary lumpectomy subjects in these
studies are mainly patients who have already received the diagnosis of malignancy before the
surgery. There is not much comprehensive work reported for patients without the diagnosis of
malignancy. In this regard, the investigators believe the intent of the innovative
oncoplastic intervention to the breast is underestimated in terms of providing diagnosis
simultaneously constituting the basic component of surgical treatment. Thus, the purpose of
this prospectively planned study is to provide and investigate the outcomes of an
evidence-based oncoplastic approach algorithm for excisional breast biopsies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04854304 -
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
|
||
Recruiting |
NCT01678170 -
Clinical Application of Breast Blood-oxygen Functional Imaging Technology
|
N/A | |
Completed |
NCT00039780 -
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel
|
Phase 3 | |
Completed |
NCT02909452 -
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
|
Phase 1 | |
Recruiting |
NCT04535466 -
Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
|
||
Recruiting |
NCT01917279 -
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
|
Phase 3 | |
Recruiting |
NCT01427400 -
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction
|
Phase 4 | |
Completed |
NCT05665894 -
Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective Analysis
|
||
Not yet recruiting |
NCT04088110 -
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
|
Phase 2 | |
Terminated |
NCT02997540 -
Effect of Body Position and Probe Position on the Localization of Breast Mass
|
||
Terminated |
NCT01140776 -
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
|
N/A | |
Recruiting |
NCT04911101 -
Performance Indicators and Patient Experience in 7G and 10G Vacuum-assisted Excision of Probably Benign Breast Lesions
|
N/A | |
Completed |
NCT04554316 -
Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery
|
N/A | |
Suspended |
NCT04151368 -
Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy
|
N/A | |
Completed |
NCT03743259 -
To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions
|
Phase 2 | |
Recruiting |
NCT04605575 -
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer
|
Phase 2 | |
Recruiting |
NCT05814224 -
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
|
N/A | |
Terminated |
NCT01372215 -
Multi-Compression Spot Mammography
|
N/A | |
Completed |
NCT00299039 -
T3AI-Pain After Breast Surgery
|
Phase 3 | |
Active, not recruiting |
NCT05441943 -
Lymphaticovenous Anastomosis as Treatment for Lymphedema
|
N/A |